Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP-001 Prophylaxis in Asthmatics Challenged with HRV-16
NCT03296917Phase 2Completed
- Sponsor
- hVIVO
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Liposomes
01
Overview
A Phase 2 trial of polyinosine-polycytidylic acid in asthma, rhinovirus infection, sponsored by hVIVO. Started Dec 2015; status: completed.
02
Drugs
polyinosine-polycytidylic acid
03
Conditions
asthmarhinovirus infection
Beyond the preview
Go deeper on NCT03296917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296917.